ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Lithium Energy Products Inc

Lithium Energy Products Inc (LEP)

0.10
0.00
(0.00%)
Cerrado 13 Enero 3:00PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.10
Postura de Compra
0.15
Postura de Venta
0.10
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.10 Rango de 52 semanas 0.10
Precio Anterior
0.10
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

LEP Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.10.10.100CS
4000.10.10.100CS
12000.10.10.100CS
26000.10.10.100CS
52000.10.10.100CS
156000.10.10.100CS
260000.10.10.100CS

LEP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Lithium Energy Products?
El precio actual de las acciones de Lithium Energy Products es $ 0.10
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Lithium Energy Products?
Lithium Energy Products ha negociado en un rango de $ 0.10 a $ 0.10 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SQGSpackman Equities Group Inc
$ 3.50
(354.55%)
59.45k
KLMKermode Resources Ltd
$ 0.01
(100.00%)
1.42M
GNFIGenifi Inc
$ 0.01
(100.00%)
2k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
JADEJade Leader Corp
$ 0.04
(60.00%)
177k
AJAAJA Health and Wellness Inc
$ 0.035
(-53.33%)
2k
BYM.HBaymount Incorporated
$ 0.005
(-50.00%)
1,000
ETUE2gold Inc
$ 0.005
(-50.00%)
12.29k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
16.04k
WWA.PWhitewater Acquisition Corp
$ 0.14
(-48.15%)
5k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
QNCQuantum Emotion Corp
$ 0.90
(-19.64%)
4.37M
GPUSAlset AI Ventures Inc
$ 0.185
(-11.90%)
4.1M
RHCRoyal Helium Ltd
$ 0.02
(0.00%)
3.47M
THRMTherma Bright Inc
$ 0.04
(-20.00%)
2.71M
tw0122 tw0122 6 minutos hace
$4.24 target one reached 
UVIX
FranCoRazon FranCoRazon 7 minutos hace
If it was correct yes. But there are a lot of assumptions and even more details not mentioned. People get more and more fooled by AI just like google.
LWLG
Wayne R Wayne R 21 minutos hace
It's a fashion statement and ecologically friendly
Investor2014 Investor2014 24 minutos hace
Whether you like it or not, it is a fact that in May 120 days will have passed since the CHMP accepted the Anavex MAA. That will be clock stop one in the EMA process, where it is highly unlikely there will no questions raised for Anavex to reply to and for which 90 days are available.

AVXL
ducci1 ducci1 27 minutos hace
Pivot Calcs: SPX Pivot--5841----R1--5875----R2--5924-----S1--5792----S2--5758----SPY Pivot--581----R1--584----S1--576-----Vix Pivot--19.30----R1--2055----R2--21.56----R3--23.82----S1--18.29 !!LOL!!
SPY
meshcan meshcan 28 minutos hace
Nobody forcing you to stay here unless you want and you most likely are benefiting from bashing Elite or shorting or day trading...otherwise what you are saying doesn't make sense.

I know many longs here are already millionaire with current price, ~0.5 pps, but I'm sure they are waiti
ELTP
along4zride along4zride 29 minutos hace
Get ready to be thrown under (FNMA) bus .
No way no how slick suit and haircut Wall Street huckster gives one cent care about hopeful investor. More than likely common share holder has been ginned up . Sheep ready for slaughter or should I say vultures .

FNMA
jxyzobrien jxyzobrien 36 minutos hace
tangerine Mussolini
Killing the market
layoffs all over
tariff news has not yet brought in long term sellers
market should be up sunday nite NOPE
Hi_Lo Hi_Lo 45 minutos hace
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents scamming pumpers and liars like you from making profits by creating bagholders here. And that's part of my goal - and to h
BCAP
DiamondHealer95 DiamondHealer95 48 minutos hace
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 54 minutos hace
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 58 minutos hace
We've invested similarly
KBLB
sunspotter sunspotter 1 hora hace
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 1 hora hace
Marc loved your ides
tinojax tinojax 1 hora hace
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 1 hora hace
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 2 horas hace
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 2 horas hace
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 2 horas hace
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)